Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
33,166,548
-
Number of holders
-
22
-
Total 13F shares, excl. options
-
2,306,452
-
Shares change
-
+3,055
-
Total reported value, excl. options
-
$3,275,197
-
Value change
-
+$4,340
-
Number of buys
-
3
-
Number of sells
-
6
-
Price
-
$1.42
Institutional Holders of Envoy Medical, Inc. - Class A Common Stock (COCH) as of Q2 2025
As of 30 Jun 2025 Envoy Medical, Inc. - Class A Common Stock (COCH) had 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,306,452 shares of stock of the company.
Largest 10 holders included Atlas Merchant Capital LLC, VANGUARD GROUP INC, Weiss Asset Management LP, Focus Partners Wealth, Arcus Capital Partners, LLC, DSG Capital Advisors, LLC, GEODE CAPITAL MANAGEMENT, LLC, CIBC Private Wealth Group LLC, MORGAN STANLEY, and HighPoint Advisor Group LLC.
This table shows 22 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.